GSE195898
microRNA profiling in the plasma of hospitalized COVID-19 patients
Coronavirus disease 2019 (COVID-19) can be asymptomatic or lead to a wide spectrum of symptoms, ranging from mild upper respiratory system involvement to acute respiratory distress syndrome, multi-organ damage and death. In this study, we explored the potential of microRNAs (miRNA) in delineating patient condition and in predicting clinical outcome. Analysis of the circulating miRNA profile of COVID-19 patients, sampled at different hospitalization intervals after admission, allowed to identify miR-144-3p as a dynamically regulated miRNA in response to COVID-19. Overall design: Plasma miRNA profiles of the COVID-19 patients sampled at different hospitalization intervals after admission with different clinical outcomes (alive or dead)